...
首页> 外文期刊>Haematologica >Label-free quantitation of phosphopeptide changes in erythrocyte membranes: towards molecular mechanisms underlying deformability alterations in stored red blood cells | Haematologica
【24h】

Label-free quantitation of phosphopeptide changes in erythrocyte membranes: towards molecular mechanisms underlying deformability alterations in stored red blood cells | Haematologica

机译:无标记的红细胞膜中磷酸肽变化的定量分析:针对潜在的红细胞变形能力改变的分子机制血液学

获取原文
           

摘要

While the probability of troublesome adverse effects related to the transfusion of older red blood cell (RBC) units is still a matter of debate and of clinical investigation, what is now known for certain is that blood storage affects the biochemical and biological properties of RBCs. The accumulating changes, collectively known as “storage lesions”, include alterations to either functionality (essentially metabolism and oxygen delivery capacity), or morphology (transition from a discoid to a spherocytic phenotype). These latter are mostly irreversible and result in a more rigid cell structure, with cytoskeleton disorders and perturbation of membrane protein interactions; therefore, they are likely the most responsible for reducing transfusion efficacy. Protein phosphorylation is known to be one of the most important and better-studied posttranslational modifications that affect protein-protein binding interfaces. Interestingly, all components of the red cell membrane skeleton (except actin) are phosphoproteins.1 Past research has demonstrated that their phosphorylation is involved in the mechanical properties of the erythrocyte membrane.2–4 However, there have been no studies at all on the phosphorylation events occurring during in vitro RBC aging. Based on these considerations, we aimed to investigate the phosphorylation status of erythrocyte membranes while undergoing blood storage for transfusion purposes by means of phosphoproteomics technologies. To this end, we decided to apply a gel-free shotgun proteomics approach to obtain qualitative phosphorylation site mapping of RBC ghosts. Specifically, packed RBCs were lysed with 9 vol of cold 5 mM phosphate buffer pH 8.0 containing 1 mM EDTA, 1mM phenylmethanesulfonyl fluoride (PMSF) and phosphatase inhibitor cocktails (P5726, P0044 Sigma-Aldrich). Two hundred micrograms of red cell membrane proteins were subjected to in-solution tryptic digestion5 followed by selective pre-enrichment of phosphorylated peptides through TiO2 affinity chromatography microcolumns.6 Eluted phosphopeptides were then analyzed by LC-MS/MS with both electron transfer dissociation (ETD) and neutral-loss triggered MS3 in collision-induced dissociation (CID), as previously reported.7 Experiments were performed in triplicate at 0-day storage time with five leuko-reduced CPD-SAGM RBC units (biological replicates) collected from different donors. Results are shown in Table 1. As expected, pTyr occurrence was very low, but in agreement with the estimated percentage,8 while numerous Ser/Thr phosphopeptides were identified. Five of these were chosen to be quantitatively monitored during storage (at 0, 21 and 35 days); selection criteria are described in Table 1. The analytical strategy adopted for the quantitation consisted in a targeted approach because we only quantified (by LC-MS) those individual peptide ions of interest that had been detected and identified previously in data-dependent LC-MS/MS experiments. In detail, targeted quantification was performed by adopting a conventional label-free MS-based workflow relying on the calculation of the extracted ion chromatogram (EIC) peak height from LC-MS runs.9,10 To minimize technical variability, each sample (i.e. 200 μg of digested erythrocyte membrane proteins) were spiked with 25 fmol/μg of bovine α-casein digest prior to TiO2 enrichment. Among the α-casein phosphopeptides detected, the one showing the lower coefficient of variation (CV) was chosen as internal standard for data normalization (i.e. YKVPQLEIVPNSpAEER, m/z 976.40, CV = 14%). Figure 1 shows graphs obtained by plotting the normalized ion intensities of each phosphopeptide versus storage time. Measurements of phosphopeptide intensity variation across all replicates for each condition resulted in CV values ranging from 16% to 40%. Quantitative data have been validated by multiple reaction monitoring (MRM)-based experiments (data not shown). Although each phosphopeptide showed a distinctive tre
机译:尽管与输注较旧的红细胞(RBC)有关的令人讨厌的不良反应的可能性仍然是辩论和临床研究的问题,但现在可以确定的是血液储存会影响RBC的生化和生物学特性。累积的变化统称为“存储损伤”,包括功能性(本质上是新陈代谢和氧气输送能力)或形态(从盘状细胞向球细胞表型的转变)的改变。后者大多数是不可逆的,并导致更刚性的细胞结构,细胞骨架紊乱和膜蛋白相互作用的扰动。因此,它们可能是降低输血功效的最主要原因。已知蛋白质磷酸化是影响蛋白质-蛋白质结合界面的最重要且研究最好的翻译后修饰之一。有趣的是,红细胞膜骨架的所有成分(肌动蛋白除外)都是磷蛋白。1过去的研究表明,它们的磷酸化与红细胞膜的机械性能有关。2–4然而,关于红细胞膜骨架的任何研究都没有。在体外红细胞老化过程中发生磷酸化事件。基于这些考虑,我们旨在研究通过磷酸化蛋白质组学技术进行输血时血细胞膜的磷酸化状态。为此,我们决定采用无凝胶shot弹枪蛋白质组学方法来获得RBC幽灵的定性磷酸化位点图。具体而言,用9体积的冷的5 mM磷酸盐缓冲液pH 8.0(含1 mM EDTA,1mM苯基甲磺酰氟(PMSF)和磷酸酶抑制剂混合物(P5726,P0044 Sigma-Aldrich))裂解包装的RBC。对200微克的红细胞膜蛋白进行溶液内胰蛋白酶消化5,然后通过TiO2亲和色谱微柱选择性地预富集磷酸化的肽。6然后通过LC-MS / MS和电子转移解离(ETD)分析洗脱的磷酸肽),并且如先前报道的那样,在碰撞诱导解离(CID)中由中性损失触发MS3。7实验在0天的储存时间一式三份,从不同供体中收集了五个白细胞减少的CPD-SAGM RBC单位(生物学重复) 。结果显示在表1中。正如预期的那样,pTyr的发生率很低,但与估计的百分比相符8,同时鉴定出许多Ser / Thr磷酸肽。选择其中的五个在存储期间(0、21和35天)进行定量监控;表1中描述了选择标准。用于定量的分析策略采用了针对性的方法,因为我们仅通过LC-MS量化了先前在依赖数据的LC-MS中检测和鉴定的那些目标肽离子。 / MS实验。详细地,通过采用基于LC-MS运行的提取离子色谱图(EIC)峰高的计算,采用常规的基于无标记物的基于MS的工作流程来进行目标定量。9,10为了最大程度地减少技术差异,每个样品(即在富集TiO2之前,将200μg消化的红细胞膜蛋白掺入25 fmol /μg的牛α-酪蛋白消化液。在检测到的α-酪蛋白磷酸肽中,选择变异系数(CV)较低的那一种作为数据标准化的内标(即YKVPQLEIVPNSpAEER,m / z 976.40,CV = 14%)。图1显示了通过绘制每种磷酸肽的归一化离子强度对储存时间的曲线图。测量每种条件下所有重复样本中磷酸肽强度的变化,得出CV值在16%至40%之间。定量数据已通过基于多反应监测(MRM)的实验验证(数据未显示)。尽管每种磷酸肽都显示出独特的

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号